AngioDynamics, Inc.

Informe acción NasdaqGS:ANGO

Capitalización de mercado: US$231.9m

Salud financiera de hoja de balance de AngioDynamics

Salud financiera controles de criterios 6/6

AngioDynamics tiene un patrimonio de los accionistas total de $218.7M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $324.8M y $106.1M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$78.45m
PatrimonioUS$218.70m
Total pasivoUS$106.14m
Activos totalesUS$324.84m

Actualizaciones recientes sobre salud financiera

Recent updates

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

AngioDynamics Shows Progress In Still-Challenging Times

Apr 08

Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

Apr 08
Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

AngioDynamics - Progress Despite Margin And Pandemic Challenges

Feb 01

Does AngioDynamics (NASDAQ:ANGO) Have A Healthy Balance Sheet?

Jan 07
Does AngioDynamics (NASDAQ:ANGO) Have A Healthy Balance Sheet?

Shareholders May Not Be So Generous With AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO Compensation And Here's Why

Oct 28
Shareholders May Not Be So Generous With AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO Compensation And Here's Why

Is AngioDynamics (NASDAQ:ANGO) Weighed On By Its Debt Load?

Oct 07
Is AngioDynamics (NASDAQ:ANGO) Weighed On By Its Debt Load?

AngioDynamics: Focusing On Three Credible Growth Drivers And Targeting Growth Acceleration

Jul 20

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($196.9M) de ANGO superan a sus pasivos a corto plazo ($85.9M).

Pasivo a largo plazo: Los activos a corto plazo de ANGO ($196.9M) superan a sus pasivos a largo plazo ($20.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: ANGO está libre de deudas.

Reducción de la deuda: ANGO no tiene deuda en comparación con hace 5 años, cuando su ratio deuda-patrimonio era de 24%.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: ANGO tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: ANGO dispone de suficiente cash runway para 2.3 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 46.4% cada año.


Descubre empresas con salud financiera